TRPV2 and dilated cardiomyopathy: On the other hand, the inhibition of TRPV2 translocation to the plasma membrane improved myocardial dysfunction, improved survival of mice with dilated cardiomyopathy and slowed the progression of dilated cardiomyopathy [17].